Colgate-Palmolive (India) Ltd
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]
- Market Cap ₹ 77,630 Cr.
- Current Price ₹ 2,854
- High / Low ₹ 3,893 / 2,351
- Stock P/E 52.8
- Book Value ₹ 60.8
- Dividend Yield 1.67 %
- ROCE 96.8 %
- ROE 74.5 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 69.8%
- Company has been maintaining a healthy dividend payout of 107%
Cons
- Stock is trading at 46.8 times its book value
- The company has delivered a poor sales growth of 4.95% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Multinational
Part of BSE 500 BSE Fast Moving Consumer Goods BSE 100 BSE 200 BSE Dollex 200
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,164 | 3,579 | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,001 | |
2,505 | 2,915 | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 3,995 | |
Operating Profit | 659 | 664 | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 2,006 |
OPM % | 21% | 19% | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 33% |
48 | 115 | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 140 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 5 |
Depreciation | 44 | 51 | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 167 |
Profit before tax | 663 | 728 | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,974 |
Tax % | 25% | 26% | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | |
497 | 540 | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,469 | |
EPS in Rs | 18.26 | 19.85 | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 54.00 |
Dividend Payout % | 77% | 68% | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 5% |
3 Years: | 5% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 12% |
3 Years: | 9% |
TTM: | 24% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 14% |
3 Years: | 27% |
1 Year: | 21% |
Return on Equity | |
---|---|
10 Years: | 63% |
5 Years: | 68% |
3 Years: | 70% |
Last Year: | 75% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 14 | 14 | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
Reserves | 476 | 586 | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,626 |
0 | 0 | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 70 | |
817 | 894 | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,525 | |
Total Liabilities | 1,307 | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,248 |
281 | 556 | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 822 | |
CWIP | 102 | 142 | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 31 |
Investments | 47 | 37 | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 |
877 | 759 | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,395 | |
Total Assets | 1,307 | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,248 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
615 | 457 | 638 | 689 | 688 | 694 | 983 | 930 | 784 | 1,626 | 1,176 | 1,199 | |
-47 | -180 | -272 | -237 | -342 | -207 | -96 | -19 | 71 | -108 | -8 | 79 | |
-428 | -422 | -385 | -391 | -341 | -380 | -815 | -891 | -956 | -1,091 | -1,087 | -1,195 | |
Net Cash Flow | 140 | -145 | -18 | 61 | 5 | 107 | 73 | 20 | -101 | 427 | 82 | 83 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 9 | 6 | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 |
Inventory Days | 54 | 59 | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 |
Days Payable | 136 | 130 | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 |
Cash Conversion Cycle | -73 | -65 | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 |
Working Capital Days | -49 | -47 | -40 | -43 | -39 | -33 | -36 | -21 | -83 | -24 | -31 | -45 |
ROCE % | 144% | 122% | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% |
Documents
Announcements
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
2d - Intimation of loss of share certificates and request for duplicates.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Dec
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3 Dec - Transcript of Investor/Analyst meet held on November 27, 2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 29 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
27 Nov - Video link of Investor/Analyst meet shared.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Dec 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Dec 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
May 2020Transcript PPT
-
May 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
May 2018Transcript PPT
-
May 2017TranscriptNotesPPT
Product Offerings
The company's product portfolio includes various SKUs of toothpaste, tooth powder, toothbrush, mouthwash, and personal care products. [1] They are sold under its well-recognized brands i.e. Colgate and Palmolive. [2]